N4-Benzoyl-7'-OH-N-trityl Morpholino cytosine structure
|
Common Name | N4-Benzoyl-7'-OH-N-trityl Morpholino cytosine | ||
---|---|---|---|---|
CAS Number | 125515-31-3 | Molecular Weight | 572.65 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C35H32N4O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of N4-Benzoyl-7'-OH-N-trityl Morpholino cytosineN4-Benzoyl-7’-OH-N-trityl morpholino cytosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
Name | N-{1-[(2R,6S)-6-(Hydroxymethyl)-4-trityl-2-morpholinyl]-2-oxo-1,2-dihydro-4-pyrimidinyl}benzamide |
---|---|
Synonym | More Synonyms |
Description | N4-Benzoyl-7’-OH-N-trityl morpholino cytosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
---|---|
Related Catalog | |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Molecular Formula | C35H32N4O4 |
Molecular Weight | 572.65 |
Exact Mass | 572.242371 |
LogP | 5.28 |
Index of Refraction | 1.649 |
Hazard Codes | Xi |
---|
MFCD22666302 |
Benzamide, N-[1,2-dihydro-1-[(2R,6S)-6-(hydroxymethyl)-4-(triphenylmethyl)-2-morpholinyl]-2-oxo-4-pyrimidinyl]- |
N-{1-[(2R,6S)-6-(Hydroxymethyl)-4-trityl-2-morpholinyl]-2-oxo-1,2-dihydro-4-pyrimidinyl}benzamide |